Clarivate (NYSE:CLVT - Get Free Report) will likely be releasing its Q1 2025 earnings data before the market opens on Tuesday, April 29th. Analysts expect Clarivate to post earnings of $0.12 per share and revenue of $574.03 million for the quarter.
Clarivate Stock Performance
CLVT traded up $0.12 during trading on Friday, hitting $3.62. 8,578,242 shares of the company traded hands, compared to its average volume of 5,134,752. Clarivate has a one year low of $3.04 and a one year high of $7.30. The stock's fifty day moving average is $3.93 and its 200 day moving average is $4.93. The firm has a market cap of $2.49 billion, a P/E ratio of -3.77 and a beta of 1.48. The company has a quick ratio of 0.88, a current ratio of 0.87 and a debt-to-equity ratio of 0.88.
Analyst Ratings Changes
Separately, Royal Bank of Canada reaffirmed a "sector perform" rating and set a $6.00 price target on shares of Clarivate in a research report on Thursday, February 20th.
View Our Latest Report on CLVT
Clarivate Company Profile
(
Get Free Report)
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Read More
Before you consider Clarivate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list.
While Clarivate currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
